Moving Life Science Innovations along the path
From Discovery To Development To Delivery
OUR VISION OF THE FUTURE: Arizona is a top-ten life science state.
OUR MISSION: AZBio supports the needs of Arizona’s growing life science ecosystem.
Arizona’s bioscience industry employed 40,399 in 2023 across 3,652 state business establishments, representing a rapid 24.6 percent increase in employment since 2019 and placing the state among the leaders in employment growth. The average wage in the bioscience industry was $102,161—53 percent higher than the state’s private sector average. Academic R&D expenditures in bioscience fields reached a new height of $683.3 million in 2022. NIH funding for Arizona totaled $366.5 million in 2023 following steady annual growth since 2019. Arizona’s bioscience companies attracted strong venture capital investment, with $281.8 million invested in 2023. Arizona stands out in patent activity in bioscience-related technology areas—its 3,387 patent awards from 2019 through 2023 places the state in the second quintile among all states. AZ-BIO2024 - state profile
IN THE LOOP
AZBio In The Loop is your opportunity to stay up to date on what is happening across Arizona's Life Science and Healthcare Community.
SubscribeAZBio Members Are Making LIFE Better
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry.
AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona's life science sector. As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed.
AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations.
Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and medtech community.
Success Stories – Good News from Arizona’s BioIndustry
CND Life Sciences Announces NIH Grant to Study the Risk of Parkinson’s Disease in Patients with Essential Tremor
SCOTTSDALE, AZ, October 22, 2025 – CND Life Sciences (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker services, today announced that it has been awarded a $3 million grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program to determine if the presence of the protein phosphorylated alpha-synuclein […]
A Decade of Impact: U of A and Banner Health transform health care in Arizona
Collaboration delivers more than $59 billion in economic impact and statewide growth in patient care, research and opportunity.
GPN Vaccines Inc Completes Acquisition of BacVax Inc.
New York, USA – 24th October 2025 – GPN Vaccines Inc (“GPN”) is pleased to announce it has successfully completed the acquisition of BacVax Inc. (“BacVax”), a biotechnology company based in Phoenix, Arizona, that is developing vaccines targeting bacterial infections.
U of A works to build a pediatric powerhouse with institute
College of Medicine – Phoenix’s Stewart Goldman and Vlad Kalinichenko have simple goal — make children’s lives better.
Events
- AZBioPEERS: Getting the Word Out - Pitching Your Story
        Oct 28, 2025 - - World Cord Blood Day 2025
        Nov 17, 2025 - - Arizona Business and Health Summit 2025
        Nov 20, 2025 - Tempe - AZBio Winter Reception at the Flinn Foundation
        Nov 20, 2025 - Phoenix - AZBio Trailblazers Luncheon
        Dec 11, 2025 - Phoenix









































































